187: AI vs. Human Pathologists: Who Sees the Biology of Glioblastoma Better?

Send us Fan Mail

Paper Discussed in this AI Journal Club:

Artificial Intelligence-Based Digital Image Analysis for Assessing Ki67, P53, and PHH3 Expression in Glioblastoma Multiforme. Devrim T, Erkilinc G, Tuncer SS. J Coll Physicians Surg Pak 2026; 36(02):153-157

Episode Summary: In this journal club deep dive, we step out of the theoretical future of AI and look at a direct, hard-data showdown between artificial intelligence and the human eye. We examine a groundbreaking 2026 study on Glioblastoma Multiforme (GBM) that forces us to ask an uncomfortable question: What happens when the AI and the human completely disagree? And more importantly, is it possible that the AI is detecting a biological reality that experienced human pathologists are entirely missing?

In This Episode, We Cover:

• The "Boss Battle" of Neuro-Oncology: Understanding Glioblastoma Multiforme (GBM), the most aggressive primary brain tumor in adults, and why precise prognosis dictates the entire treatment strategy.

• The Big Three Biomarkers (The Speedometer, The Brakes, and The Neon Sign):

    ◦ Ki67: The "speedometer" of the tumor, marking active cell proliferation.

    ◦ p53: The "guardian of the genome," acting as the emergency brakes for damaged cells. In GBM, these brakes are often broken or mutated.

    ◦ PHH3: A specific "neon mitosis tracker" that lights up dividing cells, offering a cleaner alternative to traditional manual counting.

• The Showdown - Humans vs. AI: Two experienced pathologists go head-to-head with an AI digital image analysis system (QuantCentre module by 3DHISTECH) on 20 adult GBM cases, looking at both 1 mm² and 7 mm² tumor hotspots.

• Round 1 - The Shocking Lack of Concordance: The AI and human pathologists had practically zero statistical agreement (Cohen's Kappa) on the raw numbers. The human eye acts interpretively, filtering out background noise, while the AI calculates literal pixel intensity.

• Round 2 - The AI's "Aha!" Moment: Biologically, a high proliferation rate (Ki67) must correlate with high mitosis (PHH3). Human pathologists failed to find any statistically significant link between these markers. The AI, however, found strong, biologically accurate correlations between Ki67 and PHH3, and between PHH3 and p53.

• The Future of the Lab: Why AI shouldn't replace pathologists, but rather serve as a hyper-sensitive tool to uncover hidden data patterns and personalize medicine. We also discuss the major roadblock preventing immediate clinical rollout: color standardization and image quality.

Key Takeaway: The lack of agreement between humans and machines doesn't mean the AI is wrong. By successfully identifying crucial biological relationships that humans missed due to attentional fatigue and subjectivity, the AI proved its data might actually be closer to the biological truth than our current gold standard.

Question of the Week for Our Trailblazers: Should we stop asking if the AI is as good as the human, and start asking if the human is actually precise enough to judge the AI? Let us know your thoughts!

Support the show

Get the "Digital Pathology 101" FREE E-book and join us!